🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

2,636 results for “-” Clear

  1. guanabenz acetate

    WYTENSIN

    ORAL FDA: approved

  2. guanadrel sulfate

    HYLOREL

    ORAL FDA: approved

  3. guanethidine monosulfate

    GUANETHIDINE MONOSULFATE

    ORAL FDA: approved

  4. guanfacine hydrochloride

    INTUNIV PARTIAL CHANGE APPROVAL Amneal Pharma Europe Ltd

    ORAL FDA: approved · PMDA: approved

  5. guanidine hydrochloride

    GUANIDINE HYDROCHLORIDE

    ORAL FDA: approved

  6. guideline-directed

    NMPA: clinical trials

  7. gv-

    NMPA: clinical trials

  8. haemophilus b conjugate (meningococcal protein conjugate) and hepatitis b (recombinant) vaccine

    PROCOMVAX

    EMA: unknown

    J07CA

  9. halobetasol propionate

    BRYHALI

    TOPICAL FDA: approved

  10. halofantrine hydrochloride

    HALFAN

    ORAL FDA: approved

  11. haloperidol decanoate

    HALDOL DECANOATE Teva Pharma GmbH

    INJECTION FDA: approved · TGA: approved

  12. haloperidol lactate

    HALOPERIDOL Teva Pharma GmbH

    INJECTION FDA: approved

  13. hdm1002 100 mg

    NMPA: clinical trials

  14. hdm1002 200 mg

    NMPA: clinical trials

  15. hdm1002 400 mg

    NMPA: clinical trials

  16. hdm1002 50 mg

    NMPA: clinical trials

  17. hema-

    NMPA: clinical trials

  18. heparin calcium

    CALCIPARINE

    INJECTION FDA: approved

  19. heparin sodium

    HEPARIN SODIUM CASI Pharmaceuticals

    INJECTION FDA: approved

  20. hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed)

    AMBIRIX

    EMA: approved

    J07BC20

  21. hepatitis b (rdna) vaccine (adjuvanted, adsorbed)

    FENDRIX

    EMA: approved

    J07BC01

  22. hepatitis b surface antigen

    HEPLISAV B

    EMA: approved

    J07BC01

  23. hepatitis b surface antigens recombinant (s, pre-s1, pre-s2) adsorbed on aluminium hydroxide [produced on genetically engineered murine (c127i) cells]

    HEPACARE

    EMA: withdrawn

    J07BC

  24. hepatitis b vaccine (recombinant dna)

    HBVAXPRO

    EMA: approved

    J07BC01

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources